Is Sentinel Lymph Node Mapping Indicated for Isolated Local and In-Transit Recurrent Melanoma?
- 1 November 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 238 (5), 743-747
- https://doi.org/10.1097/01.sla.0000094440.50547.1d
Abstract
To determine the feasibility of sentinel lymph node mapping in local and in-transit recurrent melanoma. The accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy (LM/SL) for identification of occult lymph node metastases is well established in primary melanoma. We hypothesized that LM/SL could be useful to detect regional node metastases in patients with isolated local and in-transit recurrent melanoma (RM). Review of our prospective melanoma database of 1600 LM/SL patients identified 30 patients who underwent LM/SL for RM. Patients with tumor-positive sentinel nodes (SNs) were considered for completion lymph node dissection. Of the 30 patients, 17 were men and 13 were women; their median age was 57 years (range, 29-86 years). Primary lesions were more often on the extremities (40%) than the head and neck (33%) or the trunk (8%). At least 1 SN was identified in each lymph node basin that drained an RM. Of the 14 (47%) patients with tumor-positive SNs, 11 (78%) underwent complete lymph node dissection; 4 had tumor-positive non-SNs. The median disease-free survival after LM/SL was 16 months (range, 1-108 months) when an SN was positive and 36 months (range, 6-132 months) when SNs were negative. At a median follow-up of 20 months (range, 2-48 months), there were no dissected basin recurrences after a tumor-negative SNs. LM/SL can accurately identify SNs draining an RM, and the high rate of SN metastases and associated poor disease-free survival for patients with tumor-positive SN suggests that LM/SL should be routinely considered in the management of patients with isolated RM.Keywords
This publication has 20 references indexed in Scilit:
- Standardized probe-directed sentinel node dissection in melanomaSurgery, 2000
- Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?Journal of the American College of Surgeons, 1999
- Are Locoregional Cutaneous Metastases in Melanoma Predictable?Annals of Surgical Oncology, 1999
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Factors affecting survival following local, regional, or distant recurrence from localized melanomaJournal of Surgical Oncology, 1998
- Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trialAnnals of Surgical Oncology, 1996
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Natural history and selective management of in transit melanomaJournal of Surgical Oncology, 1990
- Local and In-Transit Metastases Following Definitive Excision for Primary Cutaneous Malignant MelanomaAnnals of Surgery, 1983